WuXi AppTec Workshop 2019 - Discovery, IND and Beyond

Date: February 12, 2019 @ 9:00 am – @ 6:00 pm
Location: Crowne Plaza-Foster City Hotel 1221 Chess Dr Foster City, CA 94404

WuXi AppTec Workshop 2019 - Discovery, IND and Beyond

WuXi AppTec Lab Testing Division offers the knowledge, scalability and dedicated global resources to successfully

Schedule One-on-One counseling with WuXi AppTec Subject Matter Experts (Discovery, DMPK, PD, CMC, Bioanalytical, TOX, Clinical)

9:00 AM – 10:00 AM Registration/Breakfast

10:00 AM - 10:15 AM

Opening remarks (Ed Amat, VP, International Sales and Marketing, Laboratory Testing Division, WuXi AppTec)

10:15 AM - 10:45 AM

A Roadmap for a Successful IND Program (Yi Jin, PhD, DABT, VP, Chief Scientific Toxicologist & Head of WIND Project Management Laboratory Testing Division, WuXi AppTec)

10:45 AM - 11:15 AM

Summary of Discovery Phase Outcomes (Qunsheng Ji, PhD, VP, Oncology, Research Service Division, WuXi AppTec)

11:15 AM - 11:30 AM Morning Break

11:30 AM - 12:15 PM

Keynote Guest Speaker Presentation

Talazoparib : The development of a PARP inhibitor (Len Post, PhD, CSO, Vivace Therapeutics)

12:15 PM – 1:15 PM Lunch Break

1:15 PM – 2:00 PM

Keynote Guest Speaker Presentation

Nonclinical Strategies for Successful US FDA IND Submissions (Grace Furman, PhD, DABT, President & CEO, Paracelsus)

2:00 PM – 2:30 PM

ADME and PK Attributes for Drug Discovery and Development (Sharon Tong, PhD, Executive Director of DMPK, Laboratory Testing Division, WuXi AppTec)

2:30 PM – 3:00 PM

WuXi’s Services for Drug Safety Assessment (Mark Walker, Sr. Technical Director of Toxicology, Laboratory Testing Division, WuXi AppTec)

3:00 PM – 3:30 PM

Clinical Development Considerations (Bill Taaffe, Corporate Development Officer, WuXi Clinical)

3:30 PM – 3:45 PM Coffee Break

3:45 PM – 4:15 PM

Large Molecule Session - DNA to IND and Beyond: A Comprehensive & Integrated Biologic CMC Roadmap (Sherry Gu, PhD, VP, WuXi Biologics)

4:15 PM – 4:45 PM

Large Molecule Session- Bioanalytical Strategies for Large Molecule: Preclinical Studies and First-in-Human Trial (John Pirro, Sr. Director, Head of New Jersey Bioanalytical Services, Laboratory Testing Division, WuXi AppTec)

4:45 PM – 5:45 PM

Panel Discussion

Rostam Namdari, Ph.D., Senior Director, Translational Drug Development, Xenon Pharmaceuticals Inc.

Edgar Tenorio, DVM. MPVM, Nonclinical Consultant

Ronan Le Moigne, Ph.D., Senior Director, Preclinical Development and Translational Medicine, ESSA

5:45 PM – 5:50 PM Closing Remarks

6:00 PM – 7:00 PM Happy Hour Reception

https://www.eventbrite.com/e/wuxi-apptec-workshop-2019-discovery-ind-and-beyond-tickets-54671208055?aff=erelexpmlt